Author:
Karalis Vangelis,Symillides Mira,Macheras Panos
Reference32 articles.
1. Consideration of individual bioequivalence;Anderson;J. Pharmacokinet. Biopharm.,1990
2. Bioavailability and bioequivalence. definitions and difficulties in acceptance criteria;Benet,1995
3. Practical strategies and design advantages in highly variable drug studies: multiple dose and replicate administration design;Blume,1995
4. Bio-international ‘92, conference on bioavailability, bioequivalence and pharmacokinetic studies;Blume;J. Pharm. Sci.,1993
5. An approach for widening the bioequivalence acceptance limits in the case of highly variable drugs;Boddy;Pharm. Res.,1995
Cited by
22 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献